Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy.

Hulse KE, Reefer AJ, Engelhard VH, Satinover SM, Patrie JT, Chapman MD, Woodfolk JA.

J Allergy Clin Immunol. 2008 Mar;121(3):756-762.e4. Epub 2007 Dec 20.

PMID:
18086491
2.

Targeting allergen to Fc gammaRI: a strategy to treat allergic disease?

Hulse KE, Woodfolk JA.

Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):547-52. doi: 10.1097/ACI.0b013e32831665d2. Review.

4.

The major cat allergen, Fel d 1, in diagnosis and therapy.

Grönlund H, Saarne T, Gafvelin G, van Hage M.

Int Arch Allergy Immunol. 2010;151(4):265-74. doi: 10.1159/000250435. Epub 2009 Oct 22. Review.

5.

Modulation of the human IgE response.

de Vries JE, Yssel H.

Eur Respir J Suppl. 1996 Aug;22:58s-62s. Review.

PMID:
8871045
6.

A new paradigm for immunoglobulin E in allergic diseases.

Woodfolk JA.

Curr Allergy Asthma Rep. 2005 May;5(3):227-32. Review.

PMID:
15842961
7.

Peptide-mediated immunoregulation.

Hetzel C, Hoyne GF, Lamb JR.

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):275-7. Review.

PMID:
7613149
8.

[Allergies: determinants of T2 lymphocyte polarization and desensitization mechanisms].

Magnan A, Vervloet D.

Rev Mal Respir. 1997 Jun;14(3):173-81. Review. French.

PMID:
9411594
9.

Chimeric human fcgamma-allergen fusion proteins in the prevention of allergy.

Zhang K, Zhu D, Kepley C, Terada T, Saxon A.

Immunol Allergy Clin North Am. 2007 Feb;27(1):93-103. Review.

Supplemental Content

Support Center